Home › Novitas Issues Draft LCD for Non-Coverage of Opko's 4Kscore Prostate Cancer Test

Novitas Issues Draft LCD for Non-Coverage of Opko's 4Kscore Prostate Cancer Test

May 18, 2018

NEW YORK (360Dx) – Opko Health announced today that Medicare administrator Novitas Solutions has issued a draft local coverage determination of non-coverage of the company's 4Kscore test.

Opko said it plans to submit comments on the proposed LCD by the end of the comment period, ending July 5.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Clinical Lab Management

  1. Sonic Healthcare to Acquire Anatomical Pathology Provider Aurora Diagnostics

  2. TriCore Markets Lab Analytics as Standalone Service to Payors

    Premium

  3. Lab Industry Organizations File Amicus Briefs in Support of ACLA's PAMA Lawsuit

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.